Related Experiment Videos
Identifying pathways involved in leptin-dependent aggregation of human platelets.
A Corsonello1, A Malara, D De Domenico
1Italian National Research Centres on Aging (INRCA), I-87100 Cosenza, Italy. andrea_corsonello@tin.it
Summary
Leptin enhances human platelet aggregation and calcium release. Phospholipase C (PLC), phospholipase A2 (PLA2), protein kinase C (PKC), and calcium are involved in leptin
Area of Science:
- Biochemistry
- Physiology
- Hematology
Background:
- Leptin, a hormone regulating energy balance, has been implicated in cardiovascular functions.
- Platelet aggregation is a critical process in hemostasis and thrombosis.
- Understanding leptin's role in platelet function is crucial for cardiovascular health.
Purpose of the Study:
- To investigate the role of phospholipase C (PLC), phospholipase A2 (PLA2), calcium, and protein kinase C (PKC) in mediating leptin-enhanced aggregation of human platelets.
Main Methods:
- In vitro and ex vivo study involving 14 healthy male subjects.
- Adenosine diphosphate (ADP)-induced platelet aggregation and platelet free calcium were measured.
- Platelets were incubated with leptin alone or in combination with leptin receptor antibodies, PLC inhibitor (U73122), PLA2 inhibitor (AACOCF3), or PKC inhibitor (Ro31-8220).
Main Results:
- Leptin significantly increased ADP-induced platelet aggregation and platelet free calcium in a dose-dependent manner.
- Leptin's effects were blocked by anti-leptin receptor antibodies.
- Leptin-induced platelet aggregation was inhibited by PLC, PLA2, and PKC inhibitors.
- Leptin's effect on intracellular calcium was inhibited by PLC and PLA2 inhibitors, but not by the PKC inhibitor.
Conclusions:
- Leptin enhances ADP-induced aggregation of human platelets.
- Phospholipase C (PLC), phospholipase A2 (PLA2), protein kinase C (PKC), and calcium play significant roles in mediating leptin's pro-aggregating action on platelets.